Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001665160-24-000559
Filing Date
2024-04-26
Accepted
2024-04-26 13:47:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 9672
2 offeringmemoformc.pdf EX-99 35376769
  Complete submission text file 0001665160-24-000559.txt   48729678
Mailing Address 1600 FAIRVIEW AVE E STE 300 SUITE 300 SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102 2144788208
Deverra Therapeutics, Inc. (Filer) CIK: 0001822782 (see all company filings)

EIN.: 843312665 | State of Incorp.: DE
Type: C/A | Act: 33 | File No.: 020-33895 | Film No.: 24881575